aluates Reports

$ 0.0

Automative

Global NGAL Antibody Market Research Report 2026

Published Date: 2026-01-23

Report Code: QYRE-Auto-32A18482

Global NGAL Antibody Market Research Report 2024

BUY CHAPTERS

Global NGAL Antibody Market Research Report 2026

Code: QYRE-Auto-32A18482

Report

2026-01-23

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

Abcam

Hytest

Enzo Life Sciences

Biorbyt

Proteintech

Biomatik

Bio-Techne

MyBioSource

GenScript

Bioss

BioNC

NGAL Antibody Market Size

The global NGAL Antibody market was valued at US$ 136 million in 2025 and is anticipated to reach US$ 328 million by 2032, at a CAGR of 13.6% from 2026 to 2032.

NGAL Antibody Market

NGAL (Neutrophil gelatinase-associated lipocalin) is a small molecule protein expressed in neutrophils and epithelial cells of some tissues and organs, including renal tubules, and is a member of the human lipocalin family. NGAL antibody, or neutrophil gelatinase-associated lipocalin antibody, is a specific antibody against neutrophil gelatinase-associated lipocalin (NGAL), and is of great value in medical research and clinical diagnosis.

The North American market for NGAL Antibody is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for NGAL Antibody is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for NGAL Antibody in Clinic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of NGAL Antibody include Thermo Fisher Scientific, Abcam, Hytest, Enzo Life Sciences, Biorbyt, Proteintech, Biomatik, Bio-Techne, MyBioSource, GenScript, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global NGAL Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NGAL Antibody. The NGAL Antibody market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global NGAL Antibody market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist NGAL Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of NGAL Antibody Market Report

Report Metric	Details
Report Name	NGAL Antibody Market
Accounted market size in 2025	US$ 136 million
Forecasted market size in 2032	US$ 328 million
CAGR	13.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Monoclonal Antibody Polyclonal Antibody
Segment by Application	Clinic Scientific Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Abcam, Hytest, Enzo Life Sciences, Biorbyt, Proteintech, Biomatik, Bio-Techne, MyBioSource, GenScript, Bioss, BioNC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for NGAL Antibody companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is NGAL Antibody Market growing?

Ans: The NGAL Antibody Market witnessing a CAGR of 13.6% during the forecast period 2026-2032.

What is the NGAL Antibody Market size in 2032?

Ans: The NGAL Antibody Market size in 2032 will be US$ 328 million.

Who are the main players in the NGAL Antibody Market report?

Ans: The main players in the NGAL Antibody Market are Thermo Fisher Scientific, Abcam, Hytest, Enzo Life Sciences, Biorbyt, Proteintech, Biomatik, Bio-Techne, MyBioSource, GenScript, Bioss, BioNC

What are the Application segmentation covered in the NGAL Antibody Market report?

Ans: The Applications covered in the NGAL Antibody Market report are Clinic, Scientific Research

What are the Type segmentation covered in the NGAL Antibody Market report?

Ans: The Types covered in the NGAL Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NGAL Antibody Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Monoclonal Antibody

1.2.3 Polyclonal Antibody

1.3 Market by Application

1.3.1 Global NGAL Antibody Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Clinic

1.3.3 Scientific Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global NGAL Antibody Market Perspective (2021–2032)

2.2 Global NGAL Antibody Growth Trends by Region

2.2.1 Global NGAL Antibody Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 NGAL Antibody Historic Market Size by Region (2021–2026)

2.2.3 NGAL Antibody Forecasted Market Size by Region (2027–2032)

2.3 NGAL Antibody Market Dynamics

2.3.1 NGAL Antibody Industry Trends

2.3.2 NGAL Antibody Market Drivers

2.3.3 NGAL Antibody Market Challenges

2.3.4 NGAL Antibody Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NGAL Antibody Players by Revenue

3.1.1 Global Top NGAL Antibody Players by Revenue (2021–2026)

3.1.2 Global NGAL Antibody Revenue Market Share by Players (2021–2026)

3.2 Global Top NGAL Antibody Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by NGAL Antibody Revenue

3.4 Global NGAL Antibody Market Concentration Ratio

3.4.1 Global NGAL Antibody Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NGAL Antibody Revenue in 2025

3.5 Global Key Players of NGAL Antibody Head Offices and Areas Served

3.6 Global Key Players of NGAL Antibody, Products and Applications

3.7 Global Key Players of NGAL Antibody, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 NGAL Antibody Breakdown Data by Type

4.1 Global NGAL Antibody Historic Market Size by Type (2021–2026)

4.2 Global NGAL Antibody Forecasted Market Size by Type (2027–2032)

5 NGAL Antibody Breakdown Data by Application

5.1 Global NGAL Antibody Historic Market Size by Application (2021–2026)

5.2 Global NGAL Antibody Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America NGAL Antibody Market Size (2021–2032)

6.2 North America NGAL Antibody Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America NGAL Antibody Market Size by Country (2021–2026)

6.4 North America NGAL Antibody Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NGAL Antibody Market Size (2021–2032)

7.2 Europe NGAL Antibody Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe NGAL Antibody Market Size by Country (2021–2026)

7.4 Europe NGAL Antibody Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific NGAL Antibody Market Size (2021–2032)

8.2 Asia-Pacific NGAL Antibody Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific NGAL Antibody Market Size by Region (2021–2026)

8.4 Asia-Pacific NGAL Antibody Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America NGAL Antibody Market Size (2021–2032)

9.2 Latin America NGAL Antibody Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America NGAL Antibody Market Size by Country (2021–2026)

9.4 Latin America NGAL Antibody Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NGAL Antibody Market Size (2021–2032)

10.2 Middle East & Africa NGAL Antibody Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa NGAL Antibody Market Size by Country (2021–2026)

10.4 Middle East & Africa NGAL Antibody Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific NGAL Antibody Introduction

11.1.4 Thermo Fisher Scientific Revenue in NGAL Antibody Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Abcam

11.2.1 Abcam Company Details

11.2.2 Abcam Business Overview

11.2.3 Abcam NGAL Antibody Introduction

11.2.4 Abcam Revenue in NGAL Antibody Business (2021–2026)

11.2.5 Abcam Recent Development

11.3 Hytest

11.3.1 Hytest Company Details

11.3.2 Hytest Business Overview

11.3.3 Hytest NGAL Antibody Introduction

11.3.4 Hytest Revenue in NGAL Antibody Business (2021–2026)

11.3.5 Hytest Recent Development

11.4 Enzo Life Sciences

11.4.1 Enzo Life Sciences Company Details

11.4.2 Enzo Life Sciences Business Overview

11.4.3 Enzo Life Sciences NGAL Antibody Introduction

11.4.4 Enzo Life Sciences Revenue in NGAL Antibody Business (2021–2026)

11.4.5 Enzo Life Sciences Recent Development

11.5 Biorbyt

11.5.1 Biorbyt Company Details

11.5.2 Biorbyt Business Overview

11.5.3 Biorbyt NGAL Antibody Introduction

11.5.4 Biorbyt Revenue in NGAL Antibody Business (2021–2026)

11.5.5 Biorbyt Recent Development

11.6 Proteintech

11.6.1 Proteintech Company Details

11.6.2 Proteintech Business Overview

11.6.3 Proteintech NGAL Antibody Introduction

11.6.4 Proteintech Revenue in NGAL Antibody Business (2021–2026)

11.6.5 Proteintech Recent Development

11.7 Biomatik

11.7.1 Biomatik Company Details

11.7.2 Biomatik Business Overview

11.7.3 Biomatik NGAL Antibody Introduction

11.7.4 Biomatik Revenue in NGAL Antibody Business (2021–2026)

11.7.5 Biomatik Recent Development

11.8 Bio-Techne

11.8.1 Bio-Techne Company Details

11.8.2 Bio-Techne Business Overview

11.8.3 Bio-Techne NGAL Antibody Introduction

11.8.4 Bio-Techne Revenue in NGAL Antibody Business (2021–2026)

11.8.5 Bio-Techne Recent Development

11.9 MyBioSource

11.9.1 MyBioSource Company Details

11.9.2 MyBioSource Business Overview

11.9.3 MyBioSource NGAL Antibody Introduction

11.9.4 MyBioSource Revenue in NGAL Antibody Business (2021–2026)

11.9.5 MyBioSource Recent Development

11.10 GenScript

11.10.1 GenScript Company Details

11.10.2 GenScript Business Overview

11.10.3 GenScript NGAL Antibody Introduction

11.10.4 GenScript Revenue in NGAL Antibody Business (2021–2026)

11.10.5 GenScript Recent Development

11.11 Bioss

11.11.1 Bioss Company Details

11.11.2 Bioss Business Overview

11.11.3 Bioss NGAL Antibody Introduction

11.11.4 Bioss Revenue in NGAL Antibody Business (2021–2026)

11.11.5 Bioss Recent Development

11.12 BioNC

11.12.1 BioNC Company Details

11.12.2 BioNC Business Overview

11.12.3 BioNC NGAL Antibody Introduction

11.12.4 BioNC Revenue in NGAL Antibody Business (2021–2026)

11.12.5 BioNC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Abcam

Hytest

Enzo Life Sciences

Biorbyt

Proteintech

Biomatik

Bio-Techne

MyBioSource

GenScript

Bioss

BioNC

List of Tables

Table 1. Global NGAL Antibody Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Monoclonal Antibody

Table 3. Key Players of Polyclonal Antibody

Table 4. Global NGAL Antibody Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global NGAL Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global NGAL Antibody Market Size by Region (US$ Million), 2021–2026

Table 7. Global NGAL Antibody Market Share by Region (2021–2026)

Table 8. Global NGAL Antibody Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global NGAL Antibody Market Share by Region (2027–2032)

Table 10. NGAL Antibody Market Trends

Table 11. NGAL Antibody Market Drivers

Table 12. NGAL Antibody Market Challenges

Table 13. NGAL Antibody Market Restraints

Table 14. Global NGAL Antibody Revenue by Players (US$ Million), 2021–2026

Table 15. Global NGAL Antibody Market Share by Players (2021–2026)

Table 16. Global Top NGAL Antibody Players by Tier (Tier 1, Tier 2, and Tier 3), based on NGAL Antibody Revenue, 2025

Table 17. Ranking of Global Top NGAL Antibody Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by NGAL Antibody Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of NGAL Antibody, Headquarters and Area Served

Table 20. Global Key Players of NGAL Antibody, Products and Applications

Table 21. Global Key Players of NGAL Antibody, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global NGAL Antibody Market Size by Type (US$ Million), 2021–2026

Table 24. Global NGAL Antibody Revenue Market Share by Type (2021–2026)

Table 25. Global NGAL Antibody Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global NGAL Antibody Revenue Market Share by Type (2027–2032)

Table 27. Global NGAL Antibody Market Size by Application (US$ Million), 2021–2026

Table 28. Global NGAL Antibody Revenue Market Share by Application (2021–2026)

Table 29. Global NGAL Antibody Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global NGAL Antibody Revenue Market Share by Application (2027–2032)

Table 31. North America NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America NGAL Antibody Market Size by Country (US$ Million), 2021–2026

Table 33. North America NGAL Antibody Market Size by Country (US$ Million), 2027–2032

Table 34. Europe NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe NGAL Antibody Market Size by Country (US$ Million), 2021–2026

Table 36. Europe NGAL Antibody Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific NGAL Antibody Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific NGAL Antibody Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific NGAL Antibody Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America NGAL Antibody Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America NGAL Antibody Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa NGAL Antibody Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa NGAL Antibody Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa NGAL Antibody Market Size by Country (US$ Million), 2027–2032

Table 46. Thermo Fisher Scientific Company Details

Table 47. Thermo Fisher Scientific Business Overview

Table 48. Thermo Fisher Scientific NGAL Antibody Product

Table 49. Thermo Fisher Scientific Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 50. Thermo Fisher Scientific Recent Development

Table 51. Abcam Company Details

Table 52. Abcam Business Overview

Table 53. Abcam NGAL Antibody Product

Table 54. Abcam Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 55. Abcam Recent Development

Table 56. Hytest Company Details

Table 57. Hytest Business Overview

Table 58. Hytest NGAL Antibody Product

Table 59. Hytest Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 60. Hytest Recent Development

Table 61. Enzo Life Sciences Company Details

Table 62. Enzo Life Sciences Business Overview

Table 63. Enzo Life Sciences NGAL Antibody Product

Table 64. Enzo Life Sciences Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 65. Enzo Life Sciences Recent Development

Table 66. Biorbyt Company Details

Table 67. Biorbyt Business Overview

Table 68. Biorbyt NGAL Antibody Product

Table 69. Biorbyt Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 70. Biorbyt Recent Development

Table 71. Proteintech Company Details

Table 72. Proteintech Business Overview

Table 73. Proteintech NGAL Antibody Product

Table 74. Proteintech Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 75. Proteintech Recent Development

Table 76. Biomatik Company Details

Table 77. Biomatik Business Overview

Table 78. Biomatik NGAL Antibody Product

Table 79. Biomatik Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 80. Biomatik Recent Development

Table 81. Bio-Techne Company Details

Table 82. Bio-Techne Business Overview

Table 83. Bio-Techne NGAL Antibody Product

Table 84. Bio-Techne Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 85. Bio-Techne Recent Development

Table 86. MyBioSource Company Details

Table 87. MyBioSource Business Overview

Table 88. MyBioSource NGAL Antibody Product

Table 89. MyBioSource Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 90. MyBioSource Recent Development

Table 91. GenScript Company Details

Table 92. GenScript Business Overview

Table 93. GenScript NGAL Antibody Product

Table 94. GenScript Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 95. GenScript Recent Development

Table 96. Bioss Company Details

Table 97. Bioss Business Overview

Table 98. Bioss NGAL Antibody Product

Table 99. Bioss Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 100. Bioss Recent Development

Table 101. BioNC Company Details

Table 102. BioNC Business Overview

Table 103. BioNC NGAL Antibody Product

Table 104. BioNC Revenue in NGAL Antibody Business (US$ Million), 2021–2026

Table 105. BioNC Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. NGAL Antibody Picture

Figure 2. Global NGAL Antibody Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global NGAL Antibody Market Share by Type: 2025 vs 2032

Figure 4. Monoclonal Antibody Features

Figure 5. Polyclonal Antibody Features

Figure 6. Global NGAL Antibody Market Size by Application (US$ Million), 2021–2032

Figure 7. Global NGAL Antibody Market Share by Application: 2025 vs 2032

Figure 8. Clinic Case Studies

Figure 9. Scientific Research Case Studies

Figure 10. NGAL Antibody Report Years Considered

Figure 11. Global NGAL Antibody Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 12. Global NGAL Antibody Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global NGAL Antibody Market Share by Region: 2025 vs 2032

Figure 14. Global NGAL Antibody Market Share by Players in 2025

Figure 15. Global NGAL Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by NGAL Antibody Revenue in 2025

Figure 17. North America NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 18. North America NGAL Antibody Market Share by Country (2021–2032)

Figure 19. United States NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. Canada NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Europe NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe NGAL Antibody Market Share by Country (2021–2032)

Figure 23. Germany NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. France NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. U.K. NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Italy NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Russia NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Ireland NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Asia-Pacific NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific NGAL Antibody Market Share by Region (2021–2032)

Figure 31. China NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Japan NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. South Korea NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Southeast Asia NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. India NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Australia & New Zealand NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Latin America NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America NGAL Antibody Market Share by Country (2021–2032)

Figure 39. Mexico NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Brazil NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Middle East & Africa NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa NGAL Antibody Market Share by Country (2021–2032)

Figure 43. Israel NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Saudi Arabia NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. UAE NGAL Antibody Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Thermo Fisher Scientific Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 47. Abcam Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 48. Hytest Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 49. Enzo Life Sciences Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 50. Biorbyt Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 51. Proteintech Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 52. Biomatik Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 53. Bio-Techne Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 54. MyBioSource Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 55. GenScript Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 56. Bioss Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 57. BioNC Revenue Growth Rate in NGAL Antibody Business (2021–2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human NGAL Test Kit Market Research Report 2024

Global Neutrophil Gelatinase associated Lipocalin Test Kit Market Research Report 2024

Global RANKL Antibody Market Research Report 2024

Global Granulocytes Antibody Market Research Report 2024

ANGPTL6 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

LC3 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global VEGFA Antibody Market Research Report 2024

Global Granulocytes Monoclonal Antibody Market Research Report 2024

Global LIGHT Antibody Market Research Report 2024

Global Bcr Abl Antibody Market Research Report 2024

Global Bcl 2 Antibody Market Research Report 2024

Global Research Grade Antibodies Market Research Report 2024

LGR5 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Lipocalin 2 NGAL ELISA Kit Market Research Report 2024

Global Lipoprotein Lipase Antibody Market Research Report 2024

Global CD25 IL2R alpha Antibody Market Research Report 2024

Global Monoclonal Antibodies for Non small Cell Lung Cancer Market Research Report 2025

Global Lipoprotein Lipase Monoclonal Antibody Market Research Report 2024

Global GITRL Antibody Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions